Clinical Trial Update: Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4 [Phase 1]

View source ↗

Summary

This update announces the completion of a Phase 1 drug-drug interaction trial evaluating tralokinumab in patients with moderate to severe atopic dermatitis (ECZ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED